DISSECTING THE MOLECULAR AND BIOLOGICAL CONTRIBUTIONS OF THE SMARCA4 TUMOR SUPPRESSOR TO FORMATION OF SMALL CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE (SCCOHT)
$384,993FY2021Defense Health AgencyDOD
Oregon Health & Science University, Portland OR